Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

FMN reduces Amyloid-beta … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

FMN reduces Amyloid-beta toxicity in yeast by regulating redox status and cellular metabolism

Artikel i vetenskaplig tidskrift
Författare X. Chen
B. Y. Ji
Xinxin Hao
X. W. Li
Frederik Eisele
Thomas Nyström
D. Petranovic
Publicerad i Nature Communications
Volym 11
Nummer/häfte 1
ISSN 2041-1723
Publiceringsår 2020
Publicerad vid Institutionen för biomedicin
Centrum för åldrande och hälsa (AgeCap)
Språk en
Länkar dx.doi.org/10.1038/s41467-020-14525...
Ämnesord oxidative stress, alzheimers-disease, saccharomyces-cerevisiae, quality-control, protein-kinase, gene lists, riboflavin, aggregation, rna, neurodegeneration, Science & Technology - Other Topics
Ämneskategorier Neurokemi

Sammanfattning

Alzheimer's disease (AD) is defined by progressive neurodegeneration, with oligomerization and aggregation of amyloid-beta peptides (A beta) playing a pivotal role in its pathogenesis. In recent years, the yeast Saccharomyces cerevisiae has been successfully used to clarify the roles of different human proteins involved in neurodegeneration. Here, we report a genome-wide synthetic genetic interaction array to identify toxicity modifiers of A beta 42, using yeast as the model organism. We find that FMN1, the gene encoding riboflavin kinase, and its metabolic product flavin mononucleotide (FMN) reduce A beta 42 toxicity. Classic experimental analyses combined with RNAseq show the effects of FMN supplementation to include reducing misfolded protein load, altering cellular metabolism, increasing NADH/(NADH+NAD(+)) and NADPH/(NADPH+NADP(+)) ratios and increasing resistance to oxidative stress. Additionally, FMN supplementation modifies Htt103QP toxicity and alpha-synuclein toxicity in the humanized yeast. Our findings offer insights for reducing cytotoxicity of A beta 42, and potentially other misfolded proteins, via FMN-dependent cellular pathways.Saccharomyces cerevisiae is a model organism to study proteins involved in neurodegeneration. Here, the authors performed a yeast genome-wide synthetic genetic interaction array (SGA) to screen for toxicity modifiers of A beta 42 and identify riboflavin kinase and its metabolic product flavin mononucleotide as modulators that alleviate cellular A beta 42 toxicity, which is supported by further experimental analyses.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?